![]() |
市場調查報告書
商品編碼
1917963
飼料酵母市場-2026-2031年預測Feed Yeast Market - Forecast from 2026 to 2031 |
||||||
預計飼料酵母市場將從 2025 年的 17.81 億美元成長到 2031 年的 23.23 億美元,複合年成長率為 4.53%。
飼料酵母(主要為活的或去活化的釀酒酵母,以及一些特殊菌株,例如假絲酵母(Torula)和彎孢酵母屬)已成為現代單胃動物和反芻動物營養中不可或缺的功能性添加劑。活性乾酵母、酵母培養物、水解酵母和富硒衍生物在牛發揮多種作用機制:透過清除氧氣穩定瘤胃pH值;優先刺激纖維素分解菌;提高纖維消化率;降低亞急性瘤胃酸中毒(SARA)的風險;改善揮發性脂肪酸組成;並透過甘露聚醣和BETA-葡聚醣組織發揮直接的益生元作用,這些物質能夠捕獲腸道相關物質。
在禽類和豬的養殖中,酵母組成總是能提高飼料轉換率2-5%,增加絨毛高度與隱窩深度的比值,並顯著降低沙門氏菌和大腸桿菌的定植。富含核苷酸和麩胺酸的水解酵母產品擴大被添加到斷奶仔豬飼料和早期肉雞生長日糧中,以促進腸道成熟並緩解生長抑制,作為抗生素生長促進劑的替代品。目前,大多數主要市場已禁用抗生素生長促進劑。
結構性成長要素維持不變,全球肉類和蛋類需求持續上升。人均家禽消費量仍遠低於飽和水平,尤其是在亞太地區。飼料抗生素的逐步淘汰造成了永久性的市場空白,而酵母基解決方案正以經濟高效的方式填補這一空白。此外,水產養殖和寵物食品領域蛋白質結構的轉變,推動了對適口偏好好、具有免疫調節作用且不含海洋過敏原成分的需求。
亞太地區已鞏固其作為全球最大生產國和消費國的地位。中國、越南、泰國和印度擁有大規模的家禽和生豬一體化生產能力,並積極推動酪農和牛育肥場的現代化改造。本地酵母發酵能力(通常與乙醇、檸檬酸和啤酒廠相結合)使其在交付上與進口特殊添加劑競爭。北美在創新和高規格產品(有機硒酵母、富含核苷酸的水解物)方面保持主導地位,同時受益於一個由營養學家組成的成熟網路,他們積極採用基於實證的功能性飼料。
家禽在產量和產值方面仍然是領先的養殖品種。肉雞和蛋雞對添加0.5-2公斤/噸的活性酵母和酵母培養物有明顯的反應。商業性田間試驗通常顯示,飼料轉換率(FCR)提高3-6個百分點,在熱壓力和高密度飼養條件下存活率提高1-2%。蛋雞生產商擴大指定使用酵母衍生的成分,以改善無抗生素和放養系統中蛋殼品質和蛋黃穩定性。
商業產品系列已趨於成熟,並分為四個不同的類別:
成本效益計算通常顯示,在商業條件下,投資回報率為 3:1 至 8:1,這使得酵母成為後抗生素時代最具經濟吸引力的選擇之一。
總之,飼料酵母已從一種小眾添加劑發展成為家禽、豬和乳牛高性能飼料中的標準成分。其多方面的益處——瘤胃穩定、病原體控制、免疫調節和提高營養物質生物利用度——與業界在提高生產力、永續性和無抗生素認證方面的三重目標完美契合。擁有大規模、低成本發酵設施和菌株特異性功效數據的公司將繼續在該領域保持主導,儘管商業化壓力日益增大,但技術差異化仍能帶來顯著價值。
它是用來做什麼的?
產業與市場洞察、商業機會評估、產品需求預測、打入市場策略、地理擴張、資本投資決策、法律規範及其影響、新產品開發、競爭影響
Feed Yeast Market is projected to expand at a 4.53% CAGR, attaining USD 2.323 billion in 2031 from USD 1.781 billion in 2025.
Feed yeast-predominantly live or inactivated Saccharomyces cerevisiae, along with specialty strains such as Candida utilis (torula) and Kluyveromyces spp.-has become a cornerstone functional additive in modern monogastric and ruminant nutrition. Active dry yeast, yeast culture, hydrolyzed yeast, and selenium-enriched derivatives deliver multiple modes of action: stabilization of rumen pH through oxygen scavenging and preferential stimulation of cellulolytic bacteria in cattle, enhanced fiber digestibility, reduced risk of sub-acute ruminal acidosis (SARA), improved volatile fatty acid profiles, and direct prebiotic effects via mannans and B-glucans that bind enteric pathogens and modulate gut-associated lymphoid tissue.
In poultry and swine, yeast fractions consistently demonstrate 2-5 % improvements in feed conversion ratio, increased villus height:crypt depth ratios, and measurable reductions in Salmonella and E. coli colonization. Hydrolyzed yeast products rich in nucleotides and glutamic acid are increasingly specified in post-weaning piglet diets and early broiler starter phases to accelerate gut maturation and mitigate the growth check previously managed by antibiotic growth promoters now banned in most major markets.
The structural growth drivers remain unchanged: global meat and egg demand continues its upward trajectory, particularly in Asia-Pacific where per-capita poultry consumption is still far below saturation levels; regulatory phase-out of in-feed antibiotics has created a permanent void that yeast-based solutions fill cost-effectively; and the protein transition in aquaculture and pet food is elevating demand for palatable, immune-modulating ingredients that do not carry marine-allergen risk.
Asia-Pacific has solidified its position as both the largest production and consumption region. China, Vietnam, Thailand, and India combine massive poultry and swine integrator capacity with aggressive modernization of dairy and beef feedlots. Local yeast fermentation capacity-often co-located with ethanol, citric acid, or brewery plants-keeps delivered cost competitive against imported specialty additives. North America maintains leadership in innovation and high-specification products (organic selenium yeast, nucleotide-enriched hydrolysates) while benefiting from sophisticated nutritionist networks that readily adopt evidence-based functional feeds.
Poultry remains the dominant species segment by volume and value. Broilers and layers respond predictably to live yeast and yeast culture inclusion at 0.5-2 kg/t, with commercial field trials routinely reporting 3-6 points FCR improvement and 1-2 % livability gains under heat-stress or high-density conditions. Egg producers increasingly specify yeast derivatives for shell quality and yolk color stability in antibiotic-free and cage-free systems.
Commercial portfolios have matured into four distinct categories:
Cost-of-gain calculations typically show payback ratios of 3:1 to 8:1 under commercial conditions, making yeast one of the most economically attractive alternatives in the post-AGP era.
In conclusion, feed yeast has transitioned from niche additive to standard inclusion in high-performance rations across poultry, swine, and dairy. Its multifaceted benefits-rumen stabilization, pathogen control, immune modulation, and nutrient bioavailability-align perfectly with the industry's simultaneous pursuit of productivity, sustainability, and antibiotic-free certification. Companies controlling large-scale, low-cost fermentation assets while maintaining strain-specific efficacy data will continue to dominate a category where technical differentiation still commands meaningful premiums despite increasing commoditization pressure.
What do businesses use our reports for?
Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence